How much is Amplifier Therapeutics worth in 2026?

Amplifier Therapeutics has a current valuation of N/A based on their Later Stage VC (Series A) round and secondary market data.

How much funding has Amplifier Therapeutics raised?

Amplifier Therapeutics has raised N/A in total funding across 1 funding rounds.

Amplifier Therapeutics

Drug Discovery

Amplifier Therapeutics valuation and funding history | Last updated: October 17, 2023 | 1 funding rounds

Current Valuation

N/A

As of October 17, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series A)

$33.3M

Last Funding

Oct 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
October 17, 2023	Later Stage VC (Series A)	$33.3M	N/A	-

Valuation Analysis

Current Valuation Metrics

Amplifier Therapeutics is currently valued at N/A as of October 17, 2023.

Track Amplifier Therapeutics Valuation Updates

Get notified when Amplifier Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Amplifier Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Amplifier Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Amplifier Therapeutics Worth in 2026?

Amplifier Therapeutics is a leading private company in the Drug Discovery sector. Track Amplifier Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Amplifier Therapeutics Valuation is Determined

Private company valuations like Amplifier Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.